Annual ROA
-62.93%
-34.76%-123.39%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual return on assets is -62.93%, with the most recent change of -34.76% (-123.39%) on September 30, 2024.
- During the last 3 years, ARWR annual ROA has fallen by -40.08% (-175.40%).
- ARWR annual ROA is now -108.93% below its all-time high of 704.35%, reached on September 30, 1999.
Performance
ARWR ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-66.52%
+0.17%+0.25%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly return on assets is -66.52%, with the most recent change of +0.17% (+0.25%) on September 30, 2024.
- Over the past year, ARWR quarterly ROA has dropped by -6.60% (-11.01%).
- ARWR quarterly ROA is now -388.34% below its all-time high of 23.07%, reached on September 30, 2019.
Performance
ARWR Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ARWR ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -123.4% | -11.0% |
| 3 y3 years | -175.4% | -204.4% |
| 5 y5 years | -313.6% | -204.4% |
ARWR ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -175.4% | at low | -321.8% | +0.3% |
| 5 y | 5-year | -313.6% | at low | -587.0% | +0.3% |
| alltime | all time | -108.9% | +92.1% | -388.3% | +87.2% |
Arrowhead Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -62.93%(+123.4%) | -66.52%(-0.3%) |
| Jun 2024 | - | -66.69%(+11.3%) |
| Mar 2024 | - | -59.92%(+60.3%) |
| Dec 2023 | - | -37.38%(+47.0%) |
| Sep 2023 | -28.17%(+12.2%) | -25.43%(+13.0%) |
| Jun 2023 | - | -22.51%(+17.8%) |
| Mar 2023 | - | -19.11%(-9.0%) |
| Dec 2022 | - | -21.01%(-16.6%) |
| Sep 2022 | -25.11%(+9.9%) | -25.18%(+15.8%) |
| Jun 2022 | - | -21.75%(+37.9%) |
| Mar 2022 | - | -15.77%(-42.4%) |
| Dec 2021 | - | -27.40%(+25.4%) |
| Sep 2021 | -22.85%(+17.8%) | -21.85%(+6.5%) |
| Jun 2021 | - | -20.51%(+8.3%) |
| Mar 2021 | - | -18.93%(+0.6%) |
| Dec 2020 | - | -18.82%(+14.7%) |
| Sep 2020 | -19.39%(-165.8%) | -16.41%(+221.1%) |
| Jun 2020 | - | -5.11%(-332.3%) |
| Mar 2020 | - | 2.20%(-83.9%) |
| Dec 2019 | - | 13.66%(-40.8%) |
| Sep 2019 | 29.46%(-158.3%) | 23.07%(+25.3%) |
| Jun 2019 | - | 18.41%(+295.1%) |
| Mar 2019 | - | 4.66%(-124.9%) |
| Dec 2018 | - | -18.71%(-62.6%) |
| Sep 2018 | -50.50%(+70.6%) | -50.07%(+0.7%) |
| Jun 2018 | - | -49.72%(+25.9%) |
| Mar 2018 | - | -39.50%(+28.7%) |
| Dec 2017 | - | -30.68%(+10.4%) |
| Sep 2017 | -29.61%(-52.8%) | -27.80%(-27.3%) |
| Jun 2017 | - | -38.23%(-25.9%) |
| Mar 2017 | - | -51.58%(-22.0%) |
| Dec 2016 | - | -66.09%(-10.7%) |
| Sep 2016 | -62.76%(+7.5%) | -74.03%(0.0%) |
| Jun 2016 | - | -74.03%(+18.4%) |
| Mar 2016 | - | -62.52%(+0.6%) |
| Dec 2015 | - | -62.12%(+6.0%) |
| Sep 2015 | -58.36%(+9.6%) | -58.58%(+11.0%) |
| Jun 2015 | - | -52.77%(+12.2%) |
| Mar 2015 | - | -47.05%(+11.6%) |
| Dec 2014 | - | -42.17%(+2.4%) |
| Sep 2014 | -53.26%(-53.9%) | -41.17%(-5.8%) |
| Jun 2014 | - | -43.71%(-23.8%) |
| Mar 2014 | - | -57.35%(-38.5%) |
| Dec 2013 | - | -93.28%(-26.3%) |
| Sep 2013 | -115.65%(-11.3%) | -126.60%(+13.6%) |
| Jun 2013 | - | -111.42%(-27.1%) |
| Mar 2013 | - | -152.81%(+20.1%) |
| Dec 2012 | - | -127.23%(+10.9%) |
| Sep 2012 | -130.34% | -114.76%(+9.7%) |
| Jun 2012 | - | -104.66%(+47.6%) |
| Mar 2012 | - | -70.91%(+180.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | -25.26%(+16.2%) |
| Sep 2011 | -22.16%(-61.5%) | -21.74%(+30.4%) |
| Jun 2011 | - | -16.67%(+139.2%) |
| Mar 2011 | - | -6.97%(-85.5%) |
| Dec 2010 | - | -48.00%(-14.3%) |
| Sep 2010 | -57.58%(-62.8%) | -56.01%(-26.6%) |
| Jun 2010 | - | -76.29%(-30.2%) |
| Mar 2010 | - | -109.27%(-13.8%) |
| Dec 2009 | - | -126.74%(-22.9%) |
| Sep 2009 | -154.73%(+34.5%) | -164.43%(-5.9%) |
| Jun 2009 | - | -174.70%(+2.8%) |
| Mar 2009 | - | -169.89%(+21.9%) |
| Dec 2008 | - | -139.32%(+25.2%) |
| Sep 2008 | -115.01%(+23.7%) | -111.28%(+20.8%) |
| Jun 2008 | - | -92.09%(-11.4%) |
| Mar 2008 | - | -103.98%(+4.8%) |
| Dec 2007 | - | -99.22%(+7.7%) |
| Sep 2007 | -92.98%(+55.6%) | -92.16%(+10.9%) |
| Jun 2007 | - | -83.08%(+47.8%) |
| Mar 2007 | - | -56.20%(+4.5%) |
| Dec 2006 | - | -53.80%(-0.0%) |
| Sep 2006 | -59.77%(+78.6%) | -53.82%(+20.4%) |
| Jun 2006 | - | -44.71%(-8.3%) |
| Mar 2006 | - | -48.77%(+28.6%) |
| Dec 2005 | - | -37.93%(+7.6%) |
| Sep 2005 | -33.47%(-11.1%) | -35.25%(+3.2%) |
| Jun 2005 | - | -34.15%(+32.8%) |
| Mar 2005 | - | -25.71%(-36.8%) |
| Dec 2004 | - | -40.70%(+26.3%) |
| Sep 2004 | -37.64%(+212.1%) | -32.23%(+93.3%) |
| Jun 2004 | - | -16.67%(+55.4%) |
| Mar 2004 | - | -10.73%(-68.3%) |
| Dec 2003 | - | -33.87%(+22.1%) |
| Sep 2003 | -12.06%(-97.3%) | -27.74%(-94.1%) |
| Jun 2003 | - | -471.06%(-9.6%) |
| Mar 2003 | - | -520.84%(+43.9%) |
| Dec 2002 | - | -361.90%(-7.8%) |
| Sep 2002 | -448.20%(+34.4%) | -392.51%(+8.7%) |
| Jun 2002 | - | -361.03%(+13.0%) |
| Mar 2002 | - | -319.61%(-16.2%) |
| Dec 2001 | - | -381.56%(+18.9%) |
| Sep 2001 | -333.45%(+78.7%) | -321.03%(+120.8%) |
| Jun 2001 | - | -145.39%(-18.8%) |
| Mar 2001 | - | -178.98%(+1.4%) |
| Dec 2000 | - | -176.44%(-12.8%) |
| Sep 2000 | -186.59%(-126.5%) | -202.44%(-19.1%) |
| Jun 2000 | - | -250.22%(+52.6%) |
| Mar 2000 | - | -164.00%(+90.7%) |
| Dec 1999 | - | -85.98% |
| Sep 1999 | 704.35%(-513.5%) | - |
| Sep 1998 | -170.33%(-78.5%) | - |
| Sep 1997 | -793.41% | - |
FAQ
- What is Arrowhead Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual ROA year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly ROA year-on-year change?
What is Arrowhead Pharmaceuticals annual return on assets?
The current annual ROA of ARWR is -62.93%
What is the all time high annual ROA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual return on assets is 704.35%
What is Arrowhead Pharmaceuticals annual ROA year-on-year change?
Over the past year, ARWR annual return on assets has changed by -34.76% (-123.39%)
What is Arrowhead Pharmaceuticals quarterly return on assets?
The current quarterly ROA of ARWR is -66.52%
What is the all time high quarterly ROA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly return on assets is 23.07%
What is Arrowhead Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, ARWR quarterly return on assets has changed by -6.60% (-11.01%)